NASDAQ · Healthcare · Medical - Pharmaceuticals
Latigo Biotherapeutics Inc.
LTGO
Latigo Biotherapeutics, Inc. CEO Nima Farzan · Market cap $889.7M.
$14.79
-0.73 · -4.70%
52w hi $25.9352w lo $14.60
Off 52w high 17.4%
65
NOTABLE
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
0 strong · 2 notable
Analyst consensus
—
—
Section 01
Recent Form 4 filings
2 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 10 | James B. Tananbaum | Buy | 140,000 | $18.00 | +$2.52M | 65 | |
| Aug 10 | Foresite Capital Management V, LLC | Buy | 140,000 | $18.00 | +$2.52M | 65 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct